Publication & Citation Trends
Publications
0 total
Signaling via a CD28/CD40 chimeric costimulatory antigen receptor (CoStAR™), targeting folate receptor alpha, enhances T cell activity and augments tumor reactivity of tumor infiltrating lymphocytes OA
Cited by 11
Semantic Scholar
210 Generation of hypoimmunogenic allogeneic CAR T cells by inactivation of transcriptional regulators of HLA Class I and II genes OA
Cited by 0
Semantic Scholar
198 Costimulatory antigen receptor (CoStAR): a novel platform that enhances the activity of tumor infiltrating lymphocytes (TILs) OA
Cited by 3
Semantic Scholar
Cover Image OA
Cited by 0
Semantic Scholar
612 Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells OA
Cited by 0
Semantic Scholar
Toward “off‐the‐shelf” allogeneic CAR T cells OA
Cited by 32
Semantic Scholar
Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells OA
Cited by 32
Semantic Scholar
Notch Signaling Regulates the Differentiation of CLEC9A+ Dendritic Cells (cDC1) From Human and Mouse Hematopoietic Stem/Progenitor Cells OA
Cited by 0
Semantic Scholar
Research Topics
CAR-T cell therapy research
(30)
Virus-based gene therapy research
(26)
Immunotherapy and Immune Responses
(9)
Viral Infectious Diseases and Gene Expression in Insects
(9)
CRISPR and Genetic Engineering
(7)
Affiliations
Howard Hughes Medical Institute
University of California, Los Angeles
Allogene Therapeutics (United States)
Broad Center
Research Institute of Dallas